Skip to main content

3 Result(s)

within Matyas Ecsedi Remove this filter

and

  1. No Access

    Article

    Repeated mRNA vaccination sequentially boosts SARS-CoV-2-specific CD8+ T cells in persons with previous COVID-19

    Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) hybrid immunity is more protective than vaccination or previous infection alone. To investigate the kinetics of spike-reactive T (TS) cells from SARS-C...

    Emily S. Ford, Koshlan Mayer-Blackwell, Lichen **g, Kerry J. Laing… in Nature Immunology (2024)

  2. No Access

    Article

    Use of eltrombopag in aplastic anemia in Europe

    Eltrombopag (ELT), an oral thrombopoietin receptor agonist, has recently emerged as a promising new drug for the treatment of aplastic anemia (AA). How ELT is used outside of clinical trials in the real-world ...

    Matyas Ecsedi, Étienne Lengline, Cora Knol-Bout, Paul Bosman… in Annals of Hematology (2019)

  3. No Access

    Article

    Anti-thymocyte globulin-induced hyperbilirubinemia in patients with myelofibrosis undergoing allogeneic hematopoietic cell transplantation

    Allogeneic hematopoietic cell transplantation (allo-HCT) remains the only curative treatment option for myelofibrosis (MF) despite the emergence of novel targeted therapies. To reduce graft rejection and graft...

    Matyas Ecsedi, Jörg Schmohl, Robert Zeiser, Beatrice Drexler… in Annals of Hematology (2016)